Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 61 ~ 80 of 2699, Page 4 of 136
61. Medtronic EVP & CFO Karen L. Parkhill to Speak at Barclays Global Healthcare Conference
03/01/2019 Medtronic
62. Medtronic EVP & MITG President Bob White to Speak at Cowen Healthcare Conference
03/01/2019 Medtronic
63. Medtronic Announces Approval and Launch of Japan''s First DBM Bone Grafting Product for Spine and Orthopedic Procedures
Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan
02/28/2019 Medtronic
64. Medtronic Announces FDA Clearance and U.S. Launch of the Accurian Radio Frequency System for Nerve Tissue Ablation
Medtronic Expands Pain Portfolio with Minimally Invasive Therapy to Support Patients Throughout the Care Continuum
02/27/2019 Medtronic
65. Novel Technique Accurately Assesses Cardiovascular Risks
A new technique for imaging carotid arteries may provide an earlier, more accurate assessment of cardiovascular disease risk. / Volumetric multi-spectral optoacoustic tomography (vMSOT) investigates tissue at a molecular scale. / vMSOT provides information about disease-related biomarkers early enough to provide better treatment options.
02/12/2019 Radiological Society of North America
66. Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device
Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysm
02/07/2019 Medtronic
67. Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
02/06/2019 U.S. FOOD & DRUG ADMINISTRATION
68. RSNA Launches Radiology: Artificial Intelligence
OAK BROOK, Ill. (Jan. 30, 2019) ? The Radiological Society of North America (RSNA) today published the first issue of its new online journal Radiology: Artificial Intelligence.
01/30/2019 Radiological Society of North America
69. Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis, Staging, and Treatment Preparation in a Single Minimally Invasive Procedure
Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum / Medtronic Initiates Separate Study to Evaluate the Safety and Performance of the Emprint(TM) Ablation Catheter with the superDimension(TM) Navigation System for Lung Ablation Procedures
01/30/2019 Medtronic
70. Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients
New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury
01/30/2019 Medtronic
71. Statement from FDA Commissioner on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition
01/30/2019 U.S. FOOD & DRUG ADMINISTRATION
72. Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health, on a record year for device innovation
01/28/2019 U.S. FOOD & DRUG ADMINISTRATION
73. Medtronic Announces U.S. Commercial Launch of Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery
First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center
01/28/2019 Medtronic
74. RSNA in Brief-Q4 2018
To keep media informed about its current activities, the Radiological Society of North America (RSNA) distributes brief quarterly updates. For more information about any of these activities or to interview a spokesperson, contact RSNA Media Relations staff.
01/24/2019 Radiological Society of North America
75. Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio
DiamondTemp Ablation System Represents Disruptive RF Innovation
01/24/2019 Medtronic
76. Abbott Reports 2018 Results and Issues Strong Forecast for 2019
Full-year 2018 sales growth of 11.6 percent; organic sales growth of 7.3 percent / Issues financial outlook for 2019, reflecting double-digit EPS growth and 6.5 to 7.5 percent organic sales growth
01/23/2019 Abbott
77. Artificial Intelligence Shows Potential for Triaging Chest X-rays
Researchers trained an artificial intelligence system to interpret and prioritize abnormal chest X-rays with critical findings. / Chest X-rays account for 40 percent of all diagnostic imaging worldwide and create significant backlogs at health care facilities. / The AI system distinguished abnormal from normal X-rays with high accuracy.
01/22/2019 Radiological Society of North America
78. Patient-Level Survival Analysis Demonstrates No Link Between Paclitaxel Dose and Mortality in Patients Treated with IN.PACT Admiral DCB
Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency
01/22/2019 Medtronic
79. Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
With approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation
01/21/2019 Abbott
80. New Data Reinforce Benefits of Abbott’s BurstDR™ Spinal Cord Stimulation for People Living with Chronic Pain
Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation / Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices / Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication
01/19/2019 Abbott
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱